Navigation Links
Researchers Identify Sipa 1 Gene, Responsible For Cancer Metastasis

Hunter and colleagues have identified a candidate gene, Sipa1, with an amino acid polymorphism that influences metastasis in cancer. Cancer mortality is most often the result of metastasis rather than the primary tumor.//Previous studies from Kent Hunter’s group demonstrated that the genetic background of the host can influence metastatic efficiency. They expressed the polyoma middle-T transgene in various strains of inbred mice and through quantitative trait genetic mapping showed the presence of a putative metastasis efficiency locus on mouse chromosome 19. This chromosome region, which is orthologous to human 11q12-13, harbors a known metastasis suppressor gene Brms1. However, this gene has no obvious polymorphisms that influence metastasis.

Authors used a multiple cross mapping strategy that uses the shared haplotypes in different inbred strains of mice to reduce the number of candidate genes. This reduced the number of potential genes from 500 to 23, which were then prioritized base d on their known molecular function. After analyzing and discounting several of the genes, the authors found that Sipa1 had a polymorphism that results in an Alanine to threonine substitution in a protein-protein interaction domain known as a PDZ domain.

Sipa1 is a mitogen inducidble gene that encodes a GTPase activating protein (GAP) that negatively regulates RAP1 and RAP2 GTPases. Human SIPA1 has recently been found to interact with the water channel aquaporin 2 (AQP2), by its PDZ domain, so the authors used AQP2 to see if the Alanine to threonine substitution affected this interaction.

Transient transfection assays demonstrated that the FVB allele is less efficient than the DBA allele at reducing the activity of GTP-RAP1. AQP2 inhibits this and does so more effectively with the DBA allele. So, cells expressing the FVB allele will have reduced levels of Rap-GTP activity. Reducing the expression of Sipa1 in cells in vitro indicates that SIPA 1 mo dulates the adhesive properties of cells, consistent with its effect on RAP 1, which is known to affect cell-cell interactions. A series of experiment has shown that RNA Inhibiton of Sipa1 decreased the numbers of pulmonary metastases from a highly metastatic mammary tumor cell line. Conversely, over expression of the FVB allele increased the numbers of pulmonary metastases. Analysis of human tumors also demonstrated that over expression of SIPA1 is associated with metastatic progression.

The results demonstrate that Sipa1, as determined by its overall protein concentration and/or its availability to inactivate RAP1, modulates metastatic progression. Additional studies are required to verify this and to investigate another potential gene close to Sipa 1 that might also contribute to the Mtes1 locus.

Source: Nature Review Cancer.
'"/>




Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural Health ... Structural electronics involves electronic and/or electrical ... structures, replacing dumb structures such as vehicle bodies ...
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: